Plasma Metabolome Normalization in Rheumatoid Arthritis Following Initiation of Methotrexate and the Identification of Metabolic Biomarkers of Efficacy.
Plasma Metabolome Normalization in Rheumatoid Arthritis Following Initiation of Methotrexate and the Identification of Metabolic Biomarkers of Efficacy.
复制标题
甲氨蝶呤启动后类风湿关节炎的血浆代谢组归一化和疗效代谢生物标志物的鉴定。
DOI:
10.3390/metabo11120824
复制
发表时间:
2021-11-30
期刊:
影响因子:
4.1
通讯作者:
Funk RS
中科院分区:
文献类型:
--
作者:
Medcalf MR;Bhadbhade P;Mikuls TR;O'Dell JR;Gundry RL;Funk RS
Methotrexate (MTX) efficacy in the treatment of rheumatoid arthritis (RA) is variable and unpredictable, resulting in a need to identify biomarkers to guide drug therapy. This study evaluates changes in the plasma metabolome associated with response to MTX in RA with the goal of understanding the metabolic basis for MTX efficacy towards the identification of potential metabolic biomarkers of MTX response. Plasma samples were collected from healthy control subjects (n = 20), and RA patients initiating MTX therapy (n = 20, 15 mg/week) before and after 16 weeks of treatment. The samples were analyzed by a semi-targeted metabolomic analysis, and then analyzed by univariate and multivariate methods, as well as an enrichment analysis. An MTX response was defined as a clinically significant reduction in the disease activity score in 28 joints (DAS-28) of greater than 1.2; achievement of clinical remission, defined as a DAS-28 < 2.6, was also utilized as an additional measure of response. In this study, RA is associated with an altered plasma metabolome that is normalized following initiation of MTX therapy. Metabolite classes found to be altered in RA and corrected by MTX therapy were diverse and included triglycerides (p = 1.1 × 10−16), fatty acids (p = 8.0 × 10−12), and ceramides (p = 9.8 × 10−13). Stratification based on responses to MTX identified various metabolites differentially impacted in responders and non-responders including glucosylceramides (GlcCer), phosphatidylcholines (PC), sphingomyelins (SM), phosphatidylethanolamines (PE), choline, inosine, hypoxanthine, guanosine, nicotinamide, and itaconic acid (p < 0.05). In conclusion, RA is associated with significant alterations to the plasma metabolome displaying at least partial normalization following 16 weeks of MTX therapy. Changes in multiple metabolites were found to be associated with MTX efficacy, including metabolites involved in fatty acid/lipid, nucleotide, and energy metabolism.
登录
查看更多内容
DOI:
10.1002/art.40504
发表时间:
2018-07
期刊:
Arthritis & rheumatology (Hoboken, N.J.)
影响因子:
--
作者:
Falconer J;Murphy AN;Young SP;Clark AR;Tiziani S;Guma M;Buckley CD
通讯作者:
Buckley CD
影响因子:
--
作者:
Pan XH;Zhang J;Yu X;Qin L;Kang L;Zhang P
通讯作者:
Zhang P
影响因子:
3.9
作者:
Funk, Ryan S.;Singh, Rakesh K.;Becker, Mara L.
通讯作者:
Becker, Mara L.
DOI:
10.1038/nrrheum.2016.178
发表时间:
2017-01
期刊:
Nature reviews. Rheumatology
影响因子:
--
作者:
通讯作者:
--
影响因子:
4.2
作者:
Abbenhardt, Clare;Miller, Joshua W.;Ulrich, Cornelia M.
通讯作者:
Ulrich, Cornelia M.